TCM
WVE icon

Tekla Capital Management’s Wave Life Sciences WVE Stock Holding History

Tekla Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-128,146
Closed -$1.33M – 221
2020
Q2 		$1.33M Hold
128,146
– – 0.05% 184
2020
Q1 		$1.2M Buy
128,146
+28,134
+28% +$240K 0.05% 165
2019
Q4 		$802K Sell
100,012
-22,539
-18% -$553K 0.03% 183
2019
Q3 		$2.52M Buy
122,551
+66,596
+119% +$1.53M 0.11% 125
2019
Q2 		$1.46M Buy
55,955
+25,619
+84% +$718K 0.06% 147
2019
Q1 		$1.18M Buy
+30,336
New +$1.23M 0.05% 151

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tekla Capital Management's WVE Position: Q3 2020 in Review

Tekla Capital Management sold out of Wave Life Sciences (WVE) in Q3 2020, closing a stake of 128,146 shares — an estimated $1.33M sold.

Tekla Capital Management first reported a position in WVE in Q1 2019 and held it in 6 quarters. The position peaked at $2.52M in Q3 2019. 110 funds tracked by Wall St. Rank hold WVE as of Q3 2020.

  • Tekla Capital Management reported no remaining Wave Life Sciences position as of Q3 2020 after selling out during the quarter.
  • Tekla Capital Management sold 128,146 Wave Life Sciences shares in Q3 2020, an estimated $1.33M.
  • Tekla Capital Management first reported a position in Wave Life Sciences in Q1 2019 and held it in 6 quarters.
  • Tekla Capital Management's Wave Life Sciences position peaked at $2.52M in Q3 2019.
  • 110 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2020.

Based on Tekla Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.